The rapid development of AI tools was supported by both careful clinical research trials and regulation by the FDA for specific clinical applications. As these tools are now commercially available and being adopted into clinical practice, we will review best practices for enhancing the value of AI tools to: increase return on investment in AI, reduce potential bias of AI, and implement effective methods to monitor impact of AI systems within clinical practice.
Learning Objectives:
Assess the value of AI systems and describe methods to enhance return on investment.
Identify sources and types of AI bias and introduce methods to reduce bias.
Explore effective methods to monitor AI systems within clinical practice.
